ProfileGDS4718 / 221074_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 37% 44% 41% 47% 46% 39% 38% 59% 47% 47% 49% 38% 38% 37% 46% 43% 43% 40% 39% 39% 56% 45% 44% 43% 42% 38% 46% 35% 38% 39% 37% 42% 44% 45% 40% 39% 45% 53% 44% 34% 47% 43% 35% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.874637
GSM549102patient 115, normal, homogenized [OPG study]5.2337444
GSM549104patient 119, normal, homogenized [OPG study]5.0064441
GSM549108patient 138, normal, homogenized [OPG study]5.4068447
GSM549119patient 077, normal, homogenized [OPG study]5.3075746
GSM549133patient 032, cancer, homogenized [OPG study]4.8684939
GSM549139patient 042, cancer, homogenized [OPG study]4.8996138
GSM549099patient 107, normal, homogenized [OPG study]6.0358459
GSM549109patient 139, normal, homogenized [OPG study]5.3834447
GSM549110patient 046, normal, homogenized [OPG study]5.35147
GSM549114patient 063, normal, homogenized [OPG study]5.3896349
GSM549122patient 082, normal, homogenized [OPG study]4.907738
GSM549134patient 033, cancer, homogenized [OPG study]4.8739638
GSM549136patient 036, cancer, homogenized [OPG study]4.7750337
GSM549140patient 044, cancer, homogenized [OPG study]5.2824446
GSM549111patient 047, normal, homogenized [OPG study]5.1171343
GSM549113patient 057, normal, homogenized [OPG study]5.0770643
GSM549132patient 031, cancer, homogenized [OPG study]4.9585540
GSM549137patient 038, cancer, homogenized [OPG study]4.9055939
GSM549142patient 047, cancer, homogenized [OPG study]5.0610739
GSM549100patient 110, normal, homogenized [OPG study]5.8822356
GSM549107patient 135, normal, homogenized [OPG study]5.207345
GSM549115patient 068, normal, homogenized [OPG study]5.1418444
GSM549116patient 072, normal, homogenized [OPG study]5.1100443
GSM549120patient 078, normal, homogenized [OPG study]5.1001442
GSM549131patient 030, cancer, homogenized [OPG study]4.8384938
GSM549118patient 074, normal, homogenized [OPG study]5.2710846
GSM549129patient 027, cancer, homogenized [OPG study]4.7995535
GSM549123patient 088, normal, homogenized [OPG study]4.8987738
GSM549124patient 006, cancer, homogenized [OPG study]4.9720439
GSM549126patient 015, cancer, homogenized [OPG study]4.8217137
GSM549128patient 025, cancer, homogenized [OPG study]5.0549442
GSM549103patient 117, normal, homogenized [OPG study]5.269144
GSM549117patient 073, normal, homogenized [OPG study]5.1900345
GSM549138patient 041, cancer, homogenized [OPG study]4.9838540
GSM549141patient 045, cancer, homogenized [OPG study]4.8745439
GSM549130patient 028, cancer, homogenized [OPG study]5.2509745
GSM549101patient 111, normal, homogenized [OPG study]5.7161153
GSM549105patient 128, normal, homogenized [OPG study]5.2217744
GSM549106patient 134, normal, homogenized [OPG study]4.6871534
GSM549112patient 048, normal, homogenized [OPG study]5.319947
GSM549125patient 011, cancer, homogenized [OPG study]5.1454543
GSM549127patient 024, cancer, homogenized [OPG study]4.7597135
GSM549135patient 035, cancer, homogenized [OPG study]4.8593738